Clinical Trial

OverStitch NXT Endoscopic Suture System

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
To demonstrate the safety and efficacy of OverStitch NXT Endoscopic Suture System for endoscopic sleeve gastroplasty(ESG) in obese populations to support the registration of OverStitch NXT for ESG indication.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2025-11-30; most recent amendment 2026-06-28.
Trial Details
NCT Number NCT07276815
Lead Sponsor Boston Scientific Corporation
Conditions Weight Loss
Enrollment 136 participants
Start Date 2026-08-31
Primary Completion 2028-10-31 (estimated)
Study Completion 2029-10-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-29